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ABSTRACT:  
Pheochromocytoma is a rare catecholamine-secreting endocrine tumor that can cause symptoms of episodic 
hypertension, diaphoresis, anxiety, and palpitations. The catecholamine release from a pheochromocytoma 
can cause life-threatening hypertensive episodes (hypertensive emergency). We illustrate a case of 
hypertensive urgency caused by a pheochromocytoma. 
 
A 39-year-old female presented to the emergency department (ED) for the second time in one week with a 
chief complaint of high blood pressure and palpitations. Her past medical history was significant for 
hypertension (amlodipine 2.5 mg daily). Review of systems was positive for diaphoresis, shortness of breath, 
chest pain, and palpitations. Her blood pressure was 178/118 mm Hg, heart rate (HR) was 167 beats/minute. 
She was diaphoretic, distressed, hypertensive, tachycardic, and anxious. Computed tomography (CT) of the 
abdomen/pelvis showed a 10-cm heterogeneous enhancing left adrenal mass. She was started on a 
nicardipine infusion, an arterial line was placed, and she was admitted to the medical intensive care unit 
(MICU).   
 
This case serves as an example of how a very serious condition can present with subtle and common 
symptoms. Emergency physicians should consider a pheochromocytoma in their differential diagnosis for 
hypertensive emergency.  
 
Topics: Hypertensive crisis, pheochromocytoma, palpitations, shortness of breath. 
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Introduction: A pheochromocytoma is a catecholamine-
secreting endocrine tumor. Albeit rare, a pheochromocytoma 
can cause a patient to present to the ED with very common 
symptoms (eg, headache, hypertension, palpitations, 
diaphoresis, and anxiety), as we see in this case. Without a high-
level of clinical suspicion, this diagnosis can easily be missed. An 
undiagnosed pheochromocytoma can lead to end-organ 
damage and potentially lethal hypertensive crisis and, 
therefore, an emergency physician should at least consider it in 
the list of possibilities of patients presenting with symptomatic 
high blood pressure. 
 
Presenting concerns and clinical findings: A 39-year-old female 
presented to the ED with a chief complaint of high blood 
pressure. Her past medical history was significant for 
hypertension (amlodipine 2.5 mg daily). Review of systems was 
negative. Her blood pressure was 112/67 mm Hg, HR was 82 
and she was in no acute distress. Electrocardiogram (ECG), 
chest X-ray (CXR), complete blood count (CBC), basic metabolic 
panel (BMP), urinalysis (UA), B-type natriuretic peptide (BNP) 
and troponin did not show any significant abnormalities. She 
was discharged home with primary care follow-up. Three days 
later, she returned to the ED with a chief complaint of high 
blood pressure and palpitations. This time review of systems 
was positive for diaphoresis, shortness of breath, chest pain, 
and palpitations. Her blood pressure was 178/118 mm Hg; HR 
was 167 beats/minute. She was diaphoretic, distressed, 
hypertensive, tachycardic, and anxious. While gathering her 
history, she states that she had recently seen an endocrinologist 
for possible “thyroid issues” and that, if her thyroid studies 
were normal, her endocrinologist may “get a scan to look for 
other rare causes” of her hypertension.  We did not have access 
to her endocrinologist’s notes, but considering the history and 
clinical picture in this patient who was re-presenting to the ED 
with such impressive symptoms, we decided to order a CT 
abdomen/pelvis with contrast. The CT showed a 10-cm 
heterogeneous enhancing left adrenal mass.  
 
Significant findings: ED work-up: BMP within normal limits 
(WNL), white blood cell (WBC) 27.4, ECG showed sinus 
tachycardia, nonspecific ST segment abnormalities, BNP and 
troponin were within normal limits, HR 146 beats/minute, CT 
abdomen/pelvis showed a 10-cm-heterogenous enhancing left 
adrenal mass (anterior-posterior view [shown in red], lateral 
view [shown in blue]).  
 
Patient Course: After discovery of the 10-cm left adrenal mass, 
it was presumed that the patient had a pheochromocytoma. 
The patient was then started on a nicardipine infusion for blood 
pressure management, an arterial line was placed, and she was 
admitted to the MICU. Endocrinology was consulted for pre-
operative blood pressure control. Inpatient labs showed a 
plasma free normetanephrine level of 113 nmol/L and a plasma 
free metanephrine level of 4.2 nmol/L. Surgical oncology later 
excised the mass, which was then sent to pathology. The 
pathology report described a 10.5 x 10.4 cm, 324-gram 
pheochromocytoma. The patient was discharged a few days 
later on amlodipine 2.5 mg daily with endocrinology and 
surgical oncology follow-up. 
 
Discussion: As briefly mentioned in the introduction, a 
pheochromocytoma is a catecholamine-producing tumor of the 
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adrenal medulla which can cause hypertensive crisis and even 
death.1 A pheochromocytoma, although rare, can present with 
very common symptoms (eg, hypertension, anxiety, chest pain, 
diaphoresis, palpitations) which can potentially progress to 
serious life-threatening complications. During a hypertensive 
crisis, patients may develop acute pulmonary edema, confusion, 
headache, intracranial hemorrhages, heart failure, flushing, 
dysrhythmias, and other complications.1 Given that the 
presenting symptoms of a pheochromocytoma can be so 
common and that potentially life-threatening complications can 
arise, it is our belief that an emergency physician should at least 
consider this on their differential diagnoses for patients 
presenting to the ED (or re-presenting in this case) with a 
combination of these aforementioned symptoms. Patients with 
pheochromocytomas are typically diagnosed around forty years 
old.1 Classically, ten percent of pheochromocytomas are 
bilateral, ten percent are malignant, and ten percent are extra-
adrenal. This is known as the “rule of tens.”1 They can be 
associated with a genetic syndrome (eg, Von Hippel-Lindau 
disease, multiple endocrine neoplasia, neurofibromatosis type 
1), or they can be sporadic.1 Reportedly, pheochromocytomas 
occur in two to eight per million people per year.2 Diagnosis 
includes measuring fractionated metanephrines and 
catecholamines in both plasma and 24-hour urine specimens.3 
Advanced imaging (eg, CT abdomen/pelvis with contrast) can 
help with localization, treatment planning, and essentially make 
the diagnosis from the ED, as in this case. Treatment options 
consist of partial or total adrenalectomy.1 Preoperative blood 
pressure management is a serious concern for patients 
undergoing surgery due to the risk of a massive release of 
catecholamines intraoperatively.4 Therefore, patients must 
undergo strict blood pressure control preoperatively with an 
alpha-1 adrenergic antagonist (eg, phenoxybenzamine or 
phentolamine).4 Phentolamine is the preferred medication for 
an acute hypertensive crisis, but sodium nitroprusside and 
nicardipine can also be used during an acute hypertensive 
crisis.4 In this case, the patient re-presented to the ED with an 
impressive clinical picture (ie, diaphoretic, tachycardic, anxious, 
hypertensive) and a suspicious endocrine-related history. 
However, she did not complain of chest pain or back pain. She 
did not have a family history of pheochromocytoma and the 
diagnosis could have easily been missed or attributed to 
another etiology (ie, panic attack). We were fortunate to have 
the endocrine-related history component in this case, but we 
believe an emergency physician with a high clinical suspicion 
would have considered a pheochromocytoma without this 
history detail. We hope this case will further encourage 
emergency physicians to expand their differential diagnosis to 
consider life-threatening and even rare causes of common chief 
complaints, including high blood pressure. 
 
In conclusion, it is our hope that this case will encourage 
emergency physicians to consider a pheochromocytoma on 
their differential diagnosis for patients presenting with 
symptomatic high blood pressure or re-presenting to the ED 
with a combination of the aforementioned symptoms. As in this 
patient, there was no family history of pheochromocytoma and 
no complaints of back or flank pain, making misdiagnosis a high 
possibility, with potentially fatal consequences. Thankfully, the 
additional history of having an endocrinology workup in 
progress assisted in making the diagnosis in this case. 
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